MED12 and leiomyoma: Somatic MED12 mutation in exon 2 occurs at a frequency of up to 80% and has a functional role in leiomyoma initiation and progression potentially through abnormal activation of Wnt/β-catenin signaling, sex steroid receptor signaling, fibrosis-associated gene expression, and cell proliferation [12–15].